Olsson T - Search Results

1

Multiple sclerosis risk genotypes correlate with an elevated cerebrospinal fluid level of the suggested prognostic marker CXCL13.

Lindén M, Khademi M, Lima Bomfim I, Piehl F, Jagodic M, Kockum I, Olsson T. Lindén M, et al. Among authors: olsson t. Mult Scler. 2013 Jun;19(7):863-70. doi: 10.1177/1352458512463482. Epub 2012 Nov 22. Mult Scler. 2013. PMID: 23175382

2

Analysis of cerebrospinal fluid and cerebrospinal fluid cells from patients with multiple sclerosis for detection of JC virus DNA.

Iacobaeus E, Ryschkewitsch C, Gravell M, Khademi M, Wallstrom E, Olsson T, Brundin L, Major E. Iacobaeus E, et al. Among authors: olsson t. Mult Scler. 2009 Jan;15(1):28-35. doi: 10.1177/1352458508096870. Epub 2008 Sep 19. Mult Scler. 2009. PMID: 18805840 Free PMC article.

3

No evidence of IL21 association with multiple sclerosis in a Swedish population.

Lindén M, Nohra R, Sundqvist E, Khademi M, Hillert J, Alfredsson L, Olsson T, Kockum I. Lindén M, et al. Among authors: olsson t. Tissue Antigens. 2011 Oct;78(4):271-4. doi: 10.1111/j.1399-0039.2011.01734.x. Epub 2011 Jul 8. Tissue Antigens. 2011. PMID: 21736561

4

Cytomegalovirus seropositivity is negatively associated with multiple sclerosis.

Sundqvist E, Bergström T, Daialhosein H, Nyström M, Sundström P, Hillert J, Alfredsson L, Kockum I, Olsson T. Sundqvist E, et al. Among authors: olsson t. Mult Scler. 2014 Feb;20(2):165-73. doi: 10.1177/1352458513494489. Epub 2013 Sep 2. Mult Scler. 2014. PMID: 23999606

5

Reduction of both pro- and anti-inflammatory cytokines after 6 months of interferon beta-1a treatment of multiple sclerosis.

Khademi M, Wallström E, Andersson M, Piehl F, Di Marco R, Olsson T. Khademi M, et al. Among authors: olsson t. J Neuroimmunol. 2000 Mar 1;103(2):202-10. doi: 10.1016/s0165-5728(99)00184-8. J Neuroimmunol. 2000. PMID: 10696916 Clinical Trial.

6

Increased numbers of mononuclear cells from blood and CSF expressing interferon-gamma mRNA in multiple sclerosis are from both the CD4+ and the CD8+ subsets.

Wallström E, Khademi M, Andersson M, Olsson T. Wallström E, et al. Among authors: olsson t. Eur J Neurol. 2000 Jan;7(1):71-6. doi: 10.1046/j.1468-1331.2000.00027.x. Eur J Neurol. 2000. PMID: 10809917 Clinical Trial.

7

Increased brain-derived neurotrophic factor expression in white blood cells of relapsing-remitting multiple sclerosis patients.

Gielen A, Khademi M, Muhallab S, Olsson T, Piehl F. Gielen A, et al. Among authors: olsson t. Scand J Immunol. 2003 May;57(5):493-7. doi: 10.1046/j.1365-3083.2003.01260.x. Scand J Immunol. 2003. PMID: 12753507 Free article.

8

Current gene-mapping strategies in experimental models of multiple sclerosis.

Becanovic K, Jagodic M, Wallström E, Olsson T. Becanovic K, et al. Among authors: olsson t. Scand J Immunol. 2004 Jul-Aug;60(1-2):39-51. doi: 10.1111/j.0300-9475.2004.01462.x. Scand J Immunol. 2004. PMID: 15238072 Free article. Review.

9

Induction of systemic TNFalpha in natalizumab-treated multiple sclerosis.

Khademi M, Stol D, Olsson T, Wallström E. Khademi M, et al. Among authors: olsson t. Eur J Neurol. 2008 Mar;15(3):309-12. doi: 10.1111/j.1468-1331.2007.02037.x. Epub 2008 Jan 9. Eur J Neurol. 2008. PMID: 18190511

10

Inflammation and susceptibility to neurodegeneration: the use of unbiased genetics to decipher critical regulatory pathways.

Piehl F, Olsson T. Piehl F, et al. Among authors: olsson t. Neuroscience. 2009 Feb 6;158(3):1143-50. doi: 10.1016/j.neuroscience.2008.08.031. Epub 2008 Aug 27. Neuroscience. 2009. PMID: 18805461 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,244 results

Search Page

Filters